Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Sexually Transmitted Diseases

Free Subscription Articles published in Gynecol Oncol Retrieve available abstracts of 27 articles: HTML format

Single Articles

November 2026
1. VAN ARSDALE A, Gallego S, Mescheryakova O, Harmon B, et al
   HPV DNA integration is correlated with persistence or progression of cervical intraepithelial neoplasia 2 (CIN2).
   Gynecol Oncol. 2026;215:71-84.
   PubMed     Abstract available
   
   
   October 2026
2. GARDELLA B, Dominoni M, Pano MR, Lovotti A, et al
   Baseline HPV16 status and genotype multiplicity independently predict subsequent high-grade cervical lesions in HR-HPV-positive women referred for colposcopy with negative or low-grade cytology: A prospective cohort study.
   Gynecol Oncol. 2026;215:25-31.
   PubMed     Abstract available
   
   
   September 2026
3. DIXIT R, Chakrawal A, Purwar R, Pandey M, et al
   Beyond laboratory workflow: Specimen adequacy, methodological protocols, and real-world operational effectiveness in HPV self-sampling.
   Gynecol Oncol. 2026 Sep 22:S0090-8258(26)02137.
   PubMed    
   
   
   
4. WARRING SK, Knyazhanskaya EE, Garda AE, Cliby WA, et al
   Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.
   Gynecol Oncol. 2026;213:50-58.
   PubMed     Abstract available
   
   
   July 2026
5. NOGUERAS GONZALEZ GM, Amboree TL, Parker S, Bulsara S, et al
   Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system.
   Gynecol Oncol. 2026;211:238-245.
   PubMed     Abstract available
   
   
   June 2026
6. FENG P, Shi K, Zhao W, Zhang J, et al
   Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions.
   Gynecol Oncol. 2026;211:37-45.
   PubMed     Abstract available
   
   
   May 2026
7. DIXIT R, Chakrawal A, Purwar R, Pandey M, et al
   Comparative performance of HPV self-sampling and conventional screening methods: A systematic review and bivariate meta-analysis.
   Gynecol Oncol. 2026;210:84-94.
   PubMed     Abstract available
   
   
   April 2026
8. ROTHNIE K, Tristano E, Diaz-Rodriguez M, Filippova O, et al
   Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.
   Gynecol Oncol. 2026;207S:47-52.
   PubMed     Abstract available
   
   
   March 2026
9. MOREL D, Parvu V, Andrews J, Stephenson P, et al
   HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
   Gynecol Oncol. 2026;207:40-47.
   PubMed     Abstract available
   
   
   January 2026
10. JAIN D, Wahidi M, Effendi J, Hoang L, et al
    Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
    Gynecol Oncol. 2026;205:89-98.
    PubMed     Abstract available
    
    
    December 2025
11. NISHA M, Liang YL, Bateson D, Saville M, et al
    Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program.
    Gynecol Oncol. 2025;204:133-142.
    PubMed     Abstract available
    
    
    November 2025
12. ARBYN M, van den Borst E, Van Keer S, Vorsters A, et al
    Response to Dedeepy et al: Relative accuracy of HPV tests on self-collected vaginal samples or urine versus clinician-collected cervical samples.
    Gynecol Oncol. 2025 Nov 11:S0090-8258(25)01071.
    PubMed    
    
    
    October 2025
13. DEDEEPYA SD, Goel V, Desai NN
    Letter regarding "EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol".
    Gynecol Oncol. 2025 Oct 22:S0090-8258(25)01020.
    PubMed    
    
    
    September 2025
14. VAN DEN BORST E, Vanden Broeck D, De Sutter P, Donders G, et al
    EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol.
    Gynecol Oncol. 2025;202:14-23.
    PubMed     Abstract available
    
    
    
15. FULGIONE C, Inzani F, Raffone A, Raimondo D, et al
    Prognosis of HPV-independent, p53-wild-type vulvar squamous cell carcinoma: A systematic review and meta-analysis.
    Gynecol Oncol. 2025;201:210-215.
    PubMed     Abstract available
    
    
    August 2025
16. GAILLARD S, Alvarez J, Zhang T, Wang H, et al
    A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer.
    Gynecol Oncol. 2025;201:86-96.
    PubMed     Abstract available
    
    
    March 2025
17. DE BONDT D, Naslazi E, Jansen E, Kupets R, et al
    Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies.
    Gynecol Oncol. 2025;195:134-143.
    PubMed     Abstract available
    
    
    January 2025
18. MIRZA HB, Hunt A, Ennis DP, McDermott J, et al
    Spatial transcriptomic analysis reveals significant differences in tumor microenvironment in HPV-dependent and HPV-independent vulvar squamous cell carcinoma.
    Gynecol Oncol. 2025;193:65-72.
    PubMed     Abstract available
    
    
    December 2024
19. WONG TY, Adzibolosu NK, Mattei LH, Speak AC, et al
    Disparities in contemporary human papilloma virus vaccination uptake among adult women living in the United States: An All of Us Research Program study.
    Gynecol Oncol. 2024;191:100-105.
    PubMed     Abstract available
    
    
    September 2024
20. LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al
    Comparative analysis of HPV testing versus cytology in Danish cervical cancer screening: Insights from a large-scale implementation study.
    Gynecol Oncol. 2024;191:45-55.
    PubMed     Abstract available
    
    
    January 2024
21. BEFANO B, Wentzensen N, Lorey T, Poitras N, et al
    Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
    Gynecol Oncol. 2024;184:89-95.
    PubMed     Abstract available
    
    
    December 2023
22. WEBSTER EM, Ahsan MD, Kulkarni A, Penate E, et al
    Building knowledge using a novel web-based intervention to promote HPV vaccination in a diverse, low-income population.
    Gynecol Oncol. 2023;181:102-109.
    PubMed     Abstract available
    
    
    
23. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
    Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial.
    Gynecol Oncol. 2023;180:146-151.
    PubMed     Abstract available
    
    
    November 2023
24. CHEN F, Zhang GN, Lei W, Zhou SG, et al
    Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort study.
    Gynecol Oncol. 2023;178:8-13.
    PubMed     Abstract available
    
    
    May 2023
25. SCHIFFMAN M, Mirabello L, Egemen D, Befano B, et al
    The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
    Gynecol Oncol. 2023;174:253-261.
    PubMed     Abstract available
    
    
    
26. STOLER MH, Parvu V, Yanson K, Andrews J, et al
    Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2023;174:68-75.
    PubMed     Abstract available
    
    
    March 2023
27. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
    Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.
    Gynecol Oncol. 2023;170:143-152.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum